Smith & Nephew plc (S1NN34)
B3 Stock Exchange · Brazil · prices in BRL · close of 28 Oct 2026
Key indicators
| Last close | BRL 31.68 |
|---|---|
| 52-week range | 27.74 – 38.25 |
| Return, 1 month / 3 months | +13.8% / +1.4% |
| Return, 1 year / 3 years | −15.0% / +52.1% |
| Trend | Below its 200-day average |
| RSI (14) | 75 |
| Volatility (1 year) | 21.3% |
| Worst drawdown (1 year) | -26.5% |
| Average daily value traded | 0.00M BRL |
| Dividend yield | 17.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Smith & Nephew plc is a medical technology company based in the United Kingdom. It develops and makes orthopaedic implants for joint reconstruction, including hip and knee replacements, along with trauma and extremities products. The company also supplies advanced wound care dressings and devices, and arthroscopy and sports medicine instruments used in minimally invasive surgery. Its customers are hospitals, surgeons and healthcare providers around the world who use these products in surgical and clinical care.
Smith & Nephew plc is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code S1NN34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Smith & Nephew plc (S1NN34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 31.68 on 28 October 2026.
Its price-based Market X-Ray is 46 out of 100 (a weak price profile), ranking 867 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 15.0% and over the last three months it rose 1.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 41 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -1.8% | ||
| From 52-week high | -17.2% | ||
| Momentum | 38 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 1.4% | ||
| 6-month return | -5.2% | ||
| 12-month return, skipping the last month | -25.3% | ||
| Stability (higher is calmer) | 75 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.5% | ||
| Liquidity | 5 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M BRL | ||
| Zero-volume days | 88.3% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 17.9% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +14.2% |
|---|---|
| 1 month | +13.8% |
| 3 months | +1.4% |
| 6 months | −5.2% |
| 1 year | −15.0% |
| 3 years | +52.1% |
| 5 years | −8.9% |
Signals
| 50-day / 200-day average | 29.60 / 32.26 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.41 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Oct 2026 | GBP 0.3186 |
| 26 Mar 2026 | GBP 0.4718 |
| 2 Oct 2025 | GBP 0.3031 |
| 27 Mar 2025 | GBP 0.5056 |
| 3 Oct 2024 | GBP 0.3165 |
| 1 Apr 2024 | GBP 0.4650 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.